Optimal Stent Expansion and Optimization

Slides:



Advertisements
Similar presentations
Stenting: tips and tricks
Advertisements

TAVOLA ROTONDA Quale Ruolo Clinico e Quale Rimborso per la Franctional Flow Reserve? Correlazioni anatomo-funzionali FFR vs IVUS Luigi Vignali, Parma Bologna.
J BERLAND, SAINT-HILAIRE, ROUEN ST+: Stenting après pré-dilataion et ouverture de maille.
For OMA distribution only. Trademarks may be registered and are the property of their respective owners. © 2014 Medtronic, Inc. All rights reserved DOC_1A.
PCI Unmet Clinical Needs
Bifurcation Overview A comprehensive overview of Bifurcation disease, treatment options and techniques.
Bifurcation coronary stenting: State 0f the Art Mazhar M Khan Consultant Cardiologist Royal Victoria Hospital Belfast, N.Ireland.
BIFURCATION LESIONS Dr. Tahsin.N
FFR vs Angiography for Multivessel Evaluation
2 Year Clinical Outcomes from the Pivotal RESOLUTE US Study Laura Mauri MD, MSc on behalf of the RESOLUTE US Investigators Brigham and Women’s Hospital.
APPOSITION II study results Robert-Jan van Geuns, MD On behalf of the APPOSITION II Investigators.
2 Introduction Drug-eluting stents have defined a new era in the successful treatment of coronary artery disease However, like any therapy, DES results.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides
Tips and Pitfalls in Measurement of FFR during Bifurcation Stenting Nanjing first hospital Nanjing cardiovascular hospital Yefei Chenshaoliang Zhangjunjie.
Proxis Proximal embolic protection in saphenous vein graft and infarct PCI Dan Blackman Leeds General Infirmary Advanced Angioplasty 2006.
Trials of radiation to prevent or reduce in-stent restenosis Clinical Trial Commentary Dr Eric Topol Chairman and Professor, Department of Cardiology Director.
For OMA distribution only. Trademarks may be registered and are the property of their respective owners © 2015 Medtronic, Inc. All Rights Reserved DOC_1A.
Featuring CTO Complex-PCI by Trans-radial Approach CTO Case review 5 French TRI CTO of right coronary artery -5 F Launcher guiding Catheter (right Judkins.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
Which is the role of post-dilation after DES implantation? Enrico Romagnoli 1,2 M.D., Ph.D. 1 Policlinico Casilino, Roma 2 Opedale San Raffaele, Milano.
FRONTIER Registry The Guidant MULTI-LINK FRONTIER ™ Coronary Stent System for the Treatment of Pts with Native De Novo or Restenotic Bifurcation Coronary.
LM strategy Interventional cardiology dpt Cardiovascular Hospital - Lyon - France Gilles Rioufol MD PhD INSERM U1060 High Tech Marseille, 26 Janvier 2012.
TCT 2012 Revascularization Strategies for Complex Left Main Disease and Left Coronary Ostial Disease Alfredo E. Rodriguez, MD, PhD, FACC, FSCAI Centro.
左主干分叉病变治疗策略的选择 Left main bifurcation: what is the best choice? Lei Ge, MD Department of Cardiology, Zhongshan Hospital, Fudan University.
LONG-TERM OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTION FOR UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE: INITIAL CLINICAL EXPERIENCE. Graidis Ch. 1,
Cardiac catheterization Labs
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients TReated with Endothelial Progenitor Cell CapTuring Stents for De Novo.
LONG-TERM CLINICAL OUTCOMES AFTER REPEAT DRUG-ELUTING STENT IMPLANTATION FOR IN DRUG-ELUTING STENT RESTENOSIS. C. Graidis, D. Dimitriadis, A. Ntatsios,
Direct Stenting is Better (Debate Session) 동아의대 김 무 현.
For OMA distribution only. Trademarks may be registered and are the property of their respective owners. © 2013 Medtronic, Inc. All rights reserved. UC ML.
The First Affiliated Hospital of Harbin Medical University
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
For OMA distribution only. © 2014 Medtronic, Inc. All rights reserved DOC_1A 03/14 Four-Year Outcomes Following Resolute Zotarolimus-Eluting Stent.
Saqib Chowdhary Wythenshawe Hospital STENT THROMBOSIS How Do IVUS & OCT Help.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: 3D Reconstructions of Optical Frequency Domain Imaging.
Columbia University Medical Center Cardiovascular Research Foundation New York City, NY Akiko Maehara, MD Use of IVUS Reduces Stent Thrombosis and Myocardial.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implantation of a Drug-Eluting Stent With a Different.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical restenosis after coronary stenting: perspectives.
Results From the MISSION! Intervention Study Sirolimus-Eluting Stents Vs Bare-Metal Stents in Patients With STEMI : 9-Month Angiographic and Intravascular.
Philippe Généreux, MD for the Tryton Bifurcation Trial Investigators Columbia University Medical Center Cardiovascular Research Foundation New York City.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Severe Neointimal Hyperplasia of Neoplastic Carina.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Kissing Balloon or Sequential Dilation of the Side.
Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Impact of Coronary Anatomy and Stenting Technique.
Intravascular ultrasound (IVUS) in percutaneous coronary intervention – summary of key articles While angiography is routinely used for assessment of CAD,
Intravascular ultrasound (IVUS) in the treatment of long and diffuse lesions– summary of key articles Prepared by Radcliffe Cardiology 21 November2016.
Revascularization of the Heart
Global Experience with Peripheral DCBs/Stent Studies: C.R. Bard
IVUS, FFR, OCT- Which Should I Use For PCI?
(DES)+BVS +DCB for long diffuse LAD disease
How to Handle a Complex Bifurcation Lesion
BRS Summit – Scaffold Fractures
Debate: What Does the Future Hold for the Treatment of Unprotected Left Main Disease? More PCI No More Routine Surgery Ron Waksman, MD, FACC Washington.
BVS Expand: First Results of Wide Clinical Applications
Subintimal Tracking and Reentry for CTO STAR Method
OCT-Guided PCI What needs to be done to establish criteria?
The Hidden Cost of Underutilizing PCI for Chronic Total Occlusions
Stenting of Coronary Arteries in Non Stress/Benestent Disease
Circ Cardiovasc Interv
Catheter-Based Treatment of Coronary Artery Disease
Early strut coverage in patients receiving new-generation drug-eluting stents and its implications for dual antiplatelet therapy: a randomized clinical.
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
3-Year Clinical Outcomes From the RESOLUTE US Study
Bifurcation Disease: Simulation Training Curriculum
Incidence and management of restenosis after treatment of unprotected left main disease with drug-eluting stents: 70 restenotic cases from a cohort of.
FOR DISTRIBUTION BY MEDTRONIC OFFICE OF MEDICAL AFFAIRS ONLY.
Maintenance of Long-Term Clinical Benefit with
APPROACH TO CORONARY BIFURCATION LESIONS
Presentation transcript:

Optimal Stent Expansion and Optimization Non-Compliant Balloons Optimal Stent Expansion and Optimization

Non-compliant balloons Despite advances in stent technology and implantation techniques, both acute and long‐term complications still occur Stent underexpansion has been defined as a major risk factor for both of these adverse events. Thus, stent optimization after deployment is crucial Post Dilatation has been recommended to overcome these complications and provide optimal stent expansion in PCI Tasal, et al Journal of Interventional Cardiology; Vol 26, No. 4, 2013

Pre-dilatation for challenging lesions Pre-dilatation may be appropriate in treatment of complex lesions Calcified Lesions CTO’s, Angulated Lesions B2/C Lesions Bifurcations Lesions with significant calcification may be difficult to expand Pre-dilatation minimizes the risk of inadequate stent expansion Kissing balloon technique (KBT) is an important part of stent optimization, used in bifurcation lesions1 EBC recommends the use of NC Balloons to prevent over-dilatation during kissing inflations2 Initial angioplasty with small diameter balloon, followed by larger sized balloon catheters or stents Pre-dilatation may limit stent length and reduce complications3 1 Sgueglia , et.al. JACC CI 2012 2. Hildick-Smith et al. EuroIntervention 2010;6:34-38 3. Kandzari, CCI 2010

Post Dilatation for Optimal Expansion Post-Dilatation is important for optimization of stent apposition to the vessel wall1 DES studies have shown that stent under expansion is common in initial stent deployment and a strong predictor of stent thrombosis and target vessel revascularization (TVR)2 “Of 256 patients with IVUS studies [...], only 29% achieved optimum stent deployment with the stent delivery system.”4 “Inadequate stent expansion results in abnormal shear stress that might be associated with stent thrombosis.”5 Full stent apposition is key to achieving positive, long-term outcomes 2,3 1 Parikh, M. TCT 2009 2 Brodie. J Interv Cardiol. 2006 3 Fitzgerald & Leon. Netherlands Heart Journal, Volume 14, Number 9, September 2006 4 Brodie et al, CCI 2003 5 Fuji et al, Journal of the American College of Cardiology 2005

Stent Malapposition – Contributing Factors You cannot determine if a stent is well apposed based on angiography alone. Stent malapposition contributing factors include: Low pressure stent deployment Long lesions requiring multiple stents Lesions with heavy calcification Treatment of diffuse in-stent restenosis Lesions with severe stenosis Bifurcation lesions with side-branch stenting Romagnoli JACC CI 2008

Stent Deployment Optimization High pressure NC Balloons are used to ensure a uniform distribution of wall stress, maximal stent expansion and stent strut apposition. Stent Optimization Goals3: NC Balloon Attributes Complete stent apposition to the vessel wall Adequate stent expansion Full lesion coverage without edge dissection High pressure, non-compliant balloons should be used post stent-deployment1 The non-compliant balloon used is shorter and usually one-quarter size larger2 Stent optimization aims at preventing incomplete stent expansion and stent malapposition to the vessel wall after the intervention. Post-dilatation with a non-compliant (NC) balloon as opposed to a stent-mounted semicompliant balloon theoretically assures a more uniform distribution of wall stress and stent expansion and axial stent symmetry indices improve DES – NC balloons help ensure complete apposition Bifurcations – NC balloons are recommended for final KBT and post dilatation (POT) Stent optimizaiton means ensuring good apposition of stent struts to the vessel wall, such that the stent struts are not surrounded by lumen, adequate stent expansion to obtain MSA at least > 6.5 mm2 for BMSs and > 5.0 mm2 for DESs or MSA > 90% of the distal reference lumen CSA, and lack of major dissections, intramural hematomas, and geographic misses. (Yoon & Hur. Korean J Intern Med 2012) Risk of “dog bone”/ edge effect with SC balloon at high pressure NC balloon at high pressure Protruding Apposed to the intima but not embedded Malapposed No contact to the intima 1 Romagnoli et al, J.Am Coll Cardio Intv. 2008 2 Brodie. J Interven Cardiol. 2006 3 Yoon & Hur. Korean J Intern Med 2012 1Di Mario C, et al, 2008

Post Dilatation Considerations Increased procedure cost and operational inefficiencies1,2 Limits cath lab capacity and through out. Use up more resources during longer procedure time Edge Dissection/ Perforation1,2 A tear created within the tissue wall. Requires another stent and drug therapy or CABG for more severe cases Longitudinal Stent Deformation3 Balloon may get trapped. If it can not be removed may require surgery. Increased intimal damage4 Dilating the vessel more often creates more vessel trauma. Distal Embolization5 a distal filling defect with an abrupt ‘cut-off’ in one of the peripheral coronary branches of the infarct related artery, distal to the angioplasty site. Frobert PLoS ONE 2013 1,2 J. Ormiston, CRT2013)3 sciencedirect.com Intimal hyperplasia4 J. P. S. Henriques, et al European Heart Journal (2002)5

NC Balloon Characteristics NC Balloons offer the best opportunity for good stent/vessel apposition due to high pressure & low compliance1 Recommended in the stent IFUs Important NC Balloon characteristics include2: Strength/from Durable Material Incorporation of these important balloon characteristics may help to reduce the identified risks sometimes associated with Post-Dilatation High RBP (up to 20atm) Pushable and Trackable Low Radial Growth Rate Low Longitudinal Growth Rate 1 Brodie. J Interven Cardiol. 2006, 2 Stone, TCT2013

Clinical Outcomes - Post-Dilatation after Stent In this study, Post-dilatation was performed safely in patients with AMI The data show that it may reduce risk of TVR and ST without increasing adverse cardiovascular events or mortality P = 0.49 P = 0.04 P = 0.04 P = 0.10 Events at 6 month follow up Tasal, et al Journal of Interventional Cardiology; Vol 26, No. 4, 2013

Careful vessel preparation can influence TLF The RESOLUTE Japan Trial was conducted using careful lesion preparation and extensive imaging. RESOLUTE Japan TLF to 3 Yrs 4 8 12 16 20 24 28 32 36 2 6 10 Target Lesion Failure (%) 4.0% RESOLUTE Japan Lesion Prep/Imaging IVUS Use (%) 99 Pre-Dilation Pressure Range (min, max) 6.00, 24.00 Post-Dilatation (%) 78 The Japan Clinical Trial was conducted with extensive lesion preparation and extensive imaging, similar to what is recommended in the ABSORB Trials Months 100 96 95 94 93 91 Number at risk The 3-year TLF rate from RESOLUTE Japan was 4.0% No TLF creep was seen in the RESOLUTE Japan trial

Discussion Dilatation with a noncompliant balloon (NC) after stent deployment at 6 months has shown: to provide optimal stent expansion, reduced target vessel revascularization (TVR), provide better angiographic results and Improve clinical outcomes in elective PCI